0001415889-20-001398.txt : 20200601
0001415889-20-001398.hdr.sgml : 20200601
20200601171007
ACCESSION NUMBER: 0001415889-20-001398
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200601
FILED AS OF DATE: 20200601
DATE AS OF CHANGE: 20200601
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BORKOWSKI EDWARD
CENTRAL INDEX KEY: 0001197542
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37853
FILM NUMBER: 20934272
MAIL ADDRESS:
STREET 1: 1500 CORPORATE DRIVE
STREET 2: SUITE 400
CITY: CANONSBURG
STATE: PA
ZIP: 15317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AzurRx BioPharma, Inc.
CENTRAL INDEX KEY: 0001604191
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
BUSINESS PHONE: 646-699-7855
MAIL ADDRESS:
STREET 1: 760 PARKSIDE AVENUE
STREET 2: SUITE 304
CITY: BROOKLYN
STATE: NY
ZIP: 11226
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharma d'Azur, Inc.
DATE OF NAME CHANGE: 20140331
4
1
form4-06012020_020653.xml
X0306
4
2020-06-01
0001604191
AzurRx BioPharma, Inc.
AZRX
0001197542
BORKOWSKI EDWARD
C/O AZURRX BIOPHARMA, INC.
760 PARKSIDE AVE SUITE 304
BROOKLYN
NY
11226
true
false
false
false
9.0% Senior Convertible Promissory Note
0.97
2020-06-01
4
D
0
100000
100000
D
2019-12-20
2020-09-20
Common Stock
103093
0
D
9.0% Senior Convertible Promissory Note
1.07
2020-06-01
4
A
0
100000
100000
A
2019-12-20
2020-09-20
Common Stock
93458
100000
D
On June 1, 2020, AzurRx Biopharma, Inc. (the "Company") and Edward Borkowski amended the Senior Convertible Promissory Note (the "Note") previously issued on December 20, 2019 to increase the conversion price from $0.97 per share to $1.07 per share.
Represents the number of shares of the Company's common stock, par value $0.001 per share ("Common Stock") issuable upon conversion of the principal amount of the Note at the original conversion price of $0.97 per share.
Represents the number of shares of Common Stock issuable upon conversion of the principal amount of the Note at the amended conversion price of $1.07 per share.
/s/ Ed Borkowski
2020-06-01